Literature DB >> 6255660

Bovine virus diarrhoea-mucosal disease virus: pathogenicity for the fetal calf following maternal infection.

J T Done, S Terlecki, C Richardson, J W Harkness, J J Sands, D S Patterson, D Sweasey, I G Shaw, C E Winkler, S J Duffell.   

Abstract

Fifteen pregnant, bovine virus diarrhoea-mucosal disease (BVD-MD) antibody-free Jersey heifers were infected experimentally with a mixture of 10 cytopathic strains of BVD-MD virus isolated from cattle in Britain. Each cow was inoculated intramuscularly on gestation day 100 with a high or a low dose of virus grown in primary calf testis tissue cultures. None of the cows showed clinical signs of illness following exposure, but all had seroconverted within six weeks. Six fetuses, including one set of twins, died in utero following infection. Of these five were aborted between days 136 and 154; the sixth one was mummified and still retained at day 300. The remaining 10 fetuses survived to term, but all showed evidence of intrauterine growth retardation with or without gross malformation and/or dysmyelination of the central nervous system. Three were clinically affected with congenital nervous disease. Of the 10 liveborn fetuses, two had specific serum antibodies to BVD-MD. Non-cytopathic BVD-MD virus was recovered from all of the remaining eight. When non-immune cows become infected with BVD-MD virus in mid gestation: transplacental infection of the fetus will probably result; apart from the risk of fetal death, with or without abortion, there is a high probability of fetal mal-development which may not always be clinically obvious; the immunological competence of the fetus may be impaired; congenital infection is likely in a substantial proportion of liveborn calves. About one in 16 bovine fetuses in British herds are estimated to be at risk from BVD-MD virus infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255660     DOI: 10.1136/vr.106.23.473

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  28 in total

1.  Developmental Anomalies in Farm Animals: II. Defining Etiology.

Authors:  C G Rousseaux; C S Ribble
Journal:  Can Vet J       Date:  1988-01       Impact factor: 1.008

2.  A congenital defect resembling Hereford syndrome I in Alberta.

Authors:  G A Chalmers; L Rockenbach; S Marshall
Journal:  Can Vet J       Date:  1990-01       Impact factor: 1.008

3.  BVD virus antigens in tissues of persistently viraemic, clinically normal cattle: implications for the pathogenesis of clinically fatal disease.

Authors:  H Bielefeldt Ohmann
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

4.  Bovine viral diarrhoea virus-specific bovine monoclonal antibody.

Authors:  D V Onisk; S Srikumaran; C L Kelling; M L Frey
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  The duration of antibodies against bovine virus diarrhoea virus in bulk milk.

Authors:  B Fredriksen; T Løken; S A Odegaard
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

6.  Immune response to other agents of calves persistently infected with bovine virus diarrhoea virus (BVDV).

Authors:  H Houe; I Heron
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

7.  Experimental fetal infection with bovine viral diarrhea virus. II. Morphological reactions and distribution of viral antigen.

Authors:  H B Ohmann
Journal:  Can J Comp Med       Date:  1982-10

8.  Experimental fetal infection with bovine viral diarrhea virus. I. Virological and serological studies.

Authors:  H B Ohmann; M H Jensen; K J Sørensen; K Dalsgaard
Journal:  Can J Comp Med       Date:  1982-10

9.  Pestivirus infections in Norway. Serological investigations in cattle, sheep and pigs.

Authors:  T Løken; J Krogsrud; I L Larsen
Journal:  Acta Vet Scand       Date:  1991       Impact factor: 1.695

10.  Abnormal modelling of trabecular bone in calves.

Authors:  B P O'Connor; C E Doige
Journal:  Can J Vet Res       Date:  1993-01       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.